# Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment

Study · id `cardio:ct-nct01474200` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01474200](<https://clinicaltrials.gov/study/NCT01474200>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01474200

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 224 participants.

## Technical summary

Registry record NCT01474200. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-07 (actual). Results posted on 2015-10-12.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 224 participants (enrolled count; ClinicalTrials.gov record NCT01474200, source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)
- Start date: 2012-01 (registry gives no type) (ClinicalTrials.gov record NCT01474200, source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)
- Primary completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01474200, source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)
- Completion: 2014-07 (actual) (ClinicalTrials.gov record NCT01474200, source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)
- Results first posted: 2015-10-12 (ClinicalTrials.gov record NCT01474200, source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01474200, source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01474200-2023-08-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment
- Acronym: AVOID-HF
- Condition: Heart Failure
- Condition: Cardiac Failure
- Condition: Acute Decompensated Heart Failure (ADHF)
- Intervention (Device): Isolated veno-venous ultrafiltration (AQ)
- Intervention (Drug): IV Loop Diuretics (LD)
- Lead sponsor: Nuwellis, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: fe1d8bb0a30fccaa359f606437347822f6c1a886490b8314001dd6c629900c03
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
